CIART Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-55476
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: SLGGGKHQLTKHFPSHHSDSAASSPASPMEKMDQTQLGHLALKPKQPWHLTQWPAMNLTWIHTTPICNPPLSSPGTISFSHGPLGTGTGI
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CIART Antibody
Immunocytochemistry/ Immunofluorescence: CIART Antibody [NBP2-55476]
Immunocytochemistry/Immunofluorescence: C1orf51 Antibody [NBP2-55476] - Staining of human cell line MCF7 shows localization to nucleoplasm.Applications for CIART Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CIART
Alternate Names
BC017397, chromosome 1 open reading frame 51, FLJ25889, hypothetical protein LOC148523
Gene Symbol
C1ORF51
Additional CIART Products
Product Documents for CIART Antibody
Product Specific Notices for CIART Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...